WA
WST icon

Whipplewood Advisors’s West Pharmaceutical WST Stock Holding History

Whipplewood Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.27K Buy
+37
New +$9.21K ﹤0.01% 508
2025
Q3 		– Sell
-39
Closed -$8.53K – 1167
2025
Q2 		$8.53K Sell
39
-222
-85% -$47.5K ﹤0.01% 592
2025
Q1 		$8.73K Buy
261
+186
+248% +$51.3K 0.01% 585
2024
Q4 		$24.6K Buy
+75
New +$23.6K 0.01% 411

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Whipplewood Advisors's WST Position: Q1 2026 in Review

Whipplewood Advisors opened a new position in West Pharmaceutical (WST) in Q1 2026: 37 shares worth $9.27K. The stake represents ﹤0.01% of the portfolio and ranks #508 among its holdings. This is a return to the name: Whipplewood Advisors previously reported a position in WST as recently as Q2 2025.

Whipplewood Advisors first reported a position in WST in Q4 2024 and has held it in 4 quarters since. The position peaked at $24.6K in Q4 2024. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Whipplewood Advisors held 37 shares of West Pharmaceutical worth $9.27K as of Q1 2026.
  • West Pharmaceutical was a new Whipplewood Advisors position in Q1 2026.
  • West Pharmaceutical made up ﹤0.01% of Whipplewood Advisors's portfolio in Q1 2026, its #508 holding.
  • Whipplewood Advisors first reported a position in West Pharmaceutical in Q4 2024 and has held it in 4 quarters since.
  • Whipplewood Advisors's West Pharmaceutical position peaked at $24.6K in Q4 2024.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Whipplewood Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.